☰

Jennifer R. Riggs, Ph.D. - Publications

Affiliations: 
2014 Harold Abel School of Social and Behavioral Sciences Capella University, Minneapolis, MN, United States 
Area:
Industrial Psychology, Women's Studies
Tree Info Grants Similar researchers PubMed Report error

0/23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
Low-probability matches (unlikely to be authored by this person)
2021 Elsner J, Cashion D, Robinson D, Bahmanyar S, Tehrani L, Fultz KE, Narla RK, Peng X, Tran T, Apuy J, LeBrun L, Leftheris K, Boylan JF, Zhu D, Riggs JR. Structure-Guided Optimization Provides a Series of TTK Protein Inhibitors with Potent Antitumor Activity. Journal of Medicinal Chemistry. PMID 34459599 DOI: 10.1021/acs.jmedchem.1c00635  0.01
2019 Chamberlain PP, D'Agostino LA, Ellis JM, Hansen JD, Matyskiela ME, McDonald JJ, Riggs JR, Hamann LG. Evolution of Cereblon-Mediated Protein Degradation as a Therapeutic Modality. Acs Medicinal Chemistry Letters. 10: 1592-1602. PMID 31857833 DOI: 10.1021/Acsmedchemlett.9B00425  0.01
2019 Riggs JR, Elsner J, Cashion D, Robinson D, Tehrani L, Nagy M, Fultz K, Krishna Narla R, Peng X, Tran T, Kulkarni A, Bahmanyar S, Condroski K, Pagarigan B, Fenalti G, et al. Design and optimization leading to an orally active TTK protein kinase inhibitor with robust single agent efficacy. Journal of Medicinal Chemistry. PMID 30998356 DOI: 10.1021/Acs.Jmedchem.8B01869  0.01
2018 Zhu D, Xu S, Deyanat-Yazdi G, Peng SX, Barnes LA, Narla RK, Tran T, Mikolon D, Ning Y, Shi T, Jiang N, Raymon HK, Riggs JR, Boylan JF. Synthetic Lethal Strategy Identifies a Potent and Selective TTK and CLK2 Inhibitor for Treatment of Triple-negative Breast Cancer with a Compromised G1/S Checkpoint. Molecular Cancer Therapeutics. PMID 29866747 DOI: 10.1158/1535-7163.MCT-17-1084  0.01
2017 Riggs JR, Nagy M, Elsner J, Erdman P, Cashion D, Robinson D, Harris R, Huang D, Tehrani L, Deyanat-Yazdi G, Narla RK, Peng X, Tran T, Barnes L, Miller T, et al. The discovery of a dual TTK protein kinase/ CDC2-like kinase (CLK2) inhibitor for the treatment of triple negative breast cancer initiated from a phenotypic screen. Journal of Medicinal Chemistry. PMID 28991472 DOI: 10.1021/Acs.Jmedchem.7B01223  0.01
2015 Mortensen DS, Perrin-Ninkovic SM, Shevlin G, Elsner J, Zhao J, Whitefield B, Tehrani L, Sapienza J, Riggs JR, Parnes JS, Papa P, Packard G, Lee BG, Harris R, Correa M, et al. Optimization of a Series of Triazole Containing Mammalian Target of Rapamycin (mTOR) Kinase Inhibitors and the Discovery of CC-115. Journal of Medicinal Chemistry. PMID 26102506 DOI: 10.1021/Acs.Jmedchem.5B00627  0.01
2015 Mortensen DS, Perrin-Ninkovic SM, Shevlin G, Zhao J, Packard G, Bahmanyar S, Correa M, Elsner J, Harris R, Lee BG, Papa P, Parnes JS, Riggs JR, Sapienza J, Tehrani L, et al. Discovery of Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor CC-223. Journal of Medicinal Chemistry. 58: 5323-33. PMID 26083478 DOI: 10.1021/Acs.Jmedchem.5B00626  0.01
2015 Boyers LN, Karimkhani C, Riggs J, Dellavalle RP. US campus and university debit card policies regarding tobacco and electronic cigarettes. Tobacco Control. 24: 623-4. PMID 25552519 DOI: 10.1136/tobaccocontrol-2014-051957  0.01
2014 Kulkarni A, Riggs J, Phan C, Bai A, Calabrese A, Shi T, Moghaddam MF. Proposing advancement criteria for efficient DMPK triage of new chemical entities. Future Medicinal Chemistry. 6: 131-9. PMID 24467240 DOI: 10.4155/Fmc.13.190  0.01
2012 Packard GK, Papa P, Riggs JR, Erdman P, Tehrani L, Robinson D, Harris R, Shevlin G, Perrin-Ninkovic S, Hilgraf R, McCarrick MA, Tran T, Fleming Y, Bai A, Richardson S, et al. Discovery and optimization of thieno[2,3-d]pyrimidines as B-Raf inhibitors. Bioorganic & Medicinal Chemistry Letters. 22: 747-52. PMID 22137342 DOI: 10.1016/j.bmcl.2011.03.006  0.01
2012 Kumar DV, Rai R, Brameld KA, Riggs J, Somoza JR, Rajagopalan R, Janc JW, Xia YM, Ton TL, Hu H, Lehoux I, Ho JD, Young WB, Hart B, Green MJ. 3-heterocyclyl quinolone inhibitors of the HCV NS5B polymerase. Bioorganic & Medicinal Chemistry Letters. 22: 300-4. PMID 22119470 DOI: 10.1016/j.bmcl.2011.11.013  0.01
2012 Bruno TJ, Abel KR, Riggs JR. Comparison of JP-8 and JP-8+100 with the advanced distillation curve approach Energy and Fuels. 26: 5843-5850. DOI: 10.1021/ef301107z  0.01
2011 Bruno TJ, Lovestead TM, Huber ML, Riggs JR. Comparison of diesel fuel oxygenate additives to the composition-explicit distillation curve method. Part 2: Cyclic compounds with one to two oxygens Energy and Fuels. 25: 2508-2517. DOI: 10.1021/ef2003427  0.01
2011 Bruno TJ, Lovestead TM, Riggs JR, Jorgenson EL, Huber ML. Comparison of diesel fuel oxygenate additives to the composition-explicit distillation curve method. Part 1: Linear compounds with one to three oxygens Energy and Fuels. 25: 2493-2507. DOI: 10.1021/Ef2003415  0.01
2010 Lovestead TM, Windom BC, Riggs JR, Nickell C, Bruno TJ. Assessment of the compositional variability of RP-1 and RP-2 with the advanced distillation curve approach Energy and Fuels. 24: 5611-5623. DOI: 10.1021/Ef100994W  0.01
2009 Valiulin RA, Dressen DG, Riggs JR, Habte FM, Kutateladze AG. Effect of intramolecular Paternò-Büchi reaction on the thermodynamics and kinetics of nearly degenerate [3,3]-sigmatropic shift in fluxional polycycles. The Journal of Organic Chemistry. 74: 3484-90. PMID 19344135 DOI: 10.1021/Jo9003822  0.01
2006 Hu H, Kolesnikov A, Riggs JR, Wesson KE, Stephens R, Leahy EM, Shrader WD, Sprengeler PA, Green MJ, Sanford E, Nguyen M, Gjerstad E, Cabuslay R, Young WB. Potent 4-amino-5-azaindole factor VIIa inhibitors. Bioorganic & Medicinal Chemistry Letters. 16: 4567-70. PMID 16793264 DOI: 10.1016/j.bmcl.2006.06.016  0.01
2006 Vijaykumar D, Rai R, Shaghafi M, Ton T, Torkelson S, Leahy EM, Riggs JR, Hu H, Sprengeler PA, Shrader WD, O'Bryan C, Cabuslay R, Sanford E, Gjerstadt E, Liu L, et al. Efforts toward oral bioavailability in factor VIIa inhibitors. Bioorganic & Medicinal Chemistry Letters. 16: 3829-32. PMID 16650987 DOI: 10.1016/J.Bmcl.2006.04.018  0.01
2006 Riggs JR, Hu H, Kolesnikov A, Leahy EM, Wesson KE, Shrader WD, Vijaykumar D, Wahl TA, Tong Z, Sprengeler PA, Green MJ, Yu C, Katz BA, Sanford E, Nguyen M, et al. Novel 5-azaindole factor VIIa inhibitors. Bioorganic & Medicinal Chemistry Letters. 16: 3197-200. PMID 16621549 DOI: 10.1016/j.bmcl.2006.03.049  0.01
2006 Riggs JR, Kolesnikov A, Hendrix J, Young WB, Shrader WD, Vijaykumar D, Stephens R, Liu L, Pan L, Mordenti J, Green MJ, Sukbuntherng J. Factor VIIa inhibitors: a prodrug strategy to improve oral bioavailability. Bioorganic & Medicinal Chemistry Letters. 16: 2224-8. PMID 16458507 DOI: 10.1016/j.bmcl.2006.01.039  0.01
1998 Hansen MM, Riggs JR. A novel protecting group for hindered phenols Tetrahedron Letters. 39: 2705-2706. DOI: 10.1016/S0040-4039(98)00411-0  0.01
1994 Riggs JR. The impact of resource allocation and generation practices in shaping general education at the community college Community College Journal of Research and Practice. 18: 131-145. DOI: 10.1080/1066892940180203  0.01
1991 Breen LA, Gutmann L, Brick JF, Riggs JR. Paradoxical lid elevation with sustained upgaze: a sign of Lambert-Eaton syndrome. Muscle & Nerve. 14: 863-6. PMID 1922182 DOI: 10.1002/mus.880140911  0.01
Hide low-probability matches.